Cardiology

Gene therapy using 'junk DNA' could lower risk for heart disease

Scientists from UCLA and the Howard Hughes Medical Institute successfully used a gene that suppresses cholesterol levels as part of a treatment to reduce plaque in mice with a disorder called familial hypercholesterolemia. ...

Cardiology

Is very low LDL-C harmful?

A major Cardiovascular (CV) risk factor is low-density Lipoprotein Cholesterol (LDL-C). A lot of evidence that was accumulated supports a linear association between LDL-C levels and CV risk. However, whether the lower limit ...

Pediatrics

Review compares metformin, OCP for teens with PCOS

(HealthDay)—For adolescents with polycystic ovarian syndrome (PCOS), treatment with metformin and oral contraceptive pills can be beneficial, although evidence is limited, according to a review published online April 28 ...

Cardiology

Study highlights lifelong benefits of statin therapy

Stopping statin treatment early could substantially reduce lifetime protection against heart disease since a large share of the benefit occurs later in life. That's the finding of a modeling study presented at ESC Congress ...

Cardiology

Many not treated according to 2013 cholesterol guidelines

(HealthDay)—Many patients are not being treated in accordance with the 2013 American College of Cardiology/American Heart Association (ACC/AHA) cholesterol guidelines, according to a study published in the Dec. 2 issue ...

Health

Lipoprotein(a): What to know about elevated levels

If you've listened to the radio or opened a webpage in the past year, you may have seen or heard ads promoting lipoprotein(a), or Lp(a), testing to help people identify risks for heart disease.

Obstetrics & gynaecology

Women with PCOS on keto diet may see improvements in fertility

The ketogenic (keto) diet may lower testosterone levels in women with polycystic ovary syndrome (PCOS), according to a paper, titled "Effects of Ketogenic Diet on Reproductive Hormones in Women with Polycystic Ovary Syndrome," ...

Diabetes

mAb glucagon receptor blocker suitable for further development

(HealthDay)—The glucagon receptor blocker REGN1193, a fully human monoclonal antibody, seems safe and tolerable enough for further development, according to a study published online July 28 in Diabetes, Obesity and Metabolism.

page 13 from 22